Partilhar
Informação da revista
Conteúdo especial sobre o coronavírus SARS-CoV-2 (COVID-19) em Revista Portuguesa de Cardiologia
Real-world evaluation of vascular complications and comorbidities in Portuguese patients with Type 2 diabetes: Results from the cMORE study
Sílvia Alão, Tomás Silva, António Pedro Leite, Medina do Rosário, Cristina Carvalho, Joana Coelho, Hélder Ferreira, Raquel Ferreira, Joana Abreu, Margarida Rosa, Sofia Azevedo, Cláudia Cunha, Capela Daniel, Belén Juane, Renata Arantes Sousa, Ana Catarina Casais
10.1016/j.repc.2024.04.011
Acesso de texto completo
Pre-proof. Disponível online em 18 de julho de 2024
High prevalence of cardiovascular disease and risk factors among type 2 diabetes patients followed in a hospital setting in Portugal
Kashish Zehra Manjee, Danish Hassan
10.1016/j.repc.2023.09.004
Rev Port Cardiol. 2024;43:299-300
Acesso de texto completo
Clinical outcomes of percutaneous coronary intervention in chronic total occlusion in patients with type 2 diabetes mellitus
Hugo Costa, Miguel Espírito-Santo, João Bispo, João Guedes, Jorge Mimoso, Hugo Palmeiro, Rui Baptista Gonçalves, Hugo Vinhas
10.1016/j.repc.2023.07.009
Rev Port Cardiol. 2024;43:167-74
Acesso de texto completo
Percutaneous coronary intervention in chronic total occlusions: Should it be avoided in type 2 diabetic patients?
Joana Delgado-Silva
10.1016/j.repc.2023.12.005
Rev Port Cardiol. 2024;43:175-6
Acesso de texto completo
RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the one
Rodolfo P. Rothlin, Facundo Pelorosso, Mariano Duarte, Liliana Nicolosi, Ignacio Fernandez Criado, María Victoria Salgado, Héctor Vetulli
10.1016/j.repc.2023.08.005
Rev Port Cardiol. 2024;43:219-20
Acesso de texto completo
Reply to: RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the one
Jorge Gonçalves, Catarina D. Santos, Paula Fresco, Fernando Fernandez-Llimos
10.1016/j.repc.2023.10.005
Rev Port Cardiol. 2024;43:221-2
Acesso de texto completo
Hypertrophic cardiomyopathy: Paradigm shifts in the last 30 years (Part 2)
Nuno Cardim
10.1016/j.repc.2023.12.008
Acesso de texto completo
Disponível online em 26 de março de 2024
RAAS inhibitors in COVID-19: They are not all the same!
Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan
10.1016/j.repc.2023.04.008
Rev Port Cardiol. 2023;42:815-6
Acesso de texto completo
Reply to: RAAS inhibitors in COVID-19: Not all are created equal!
Jorge Gonçalves, Catarina D. Santos, Paula Fresco, Fernando Fernandez-Llimos
10.1016/j.repc.2023.06.003
Rev Port Cardiol. 2023;42:817-8
Acesso de texto completo
High prevalence of cardiovascular disease and risk factors among type 2 diabetes patients followed in a hospital setting in Portugal: The PICT2RE observational study
Helena Cardoso, Carlos Tavares Bello, Luís Andrade, Francisco Sobral do Rosário, Joana Louro, Cláudia Nogueira, Elisabete Rodrigues, Nuno Bernardino Vieira, Teresa Carqueja
10.1016/j.repc.2022.04.011
Rev Port Cardiol. 2023;42:319-30
Acesso de texto completo
Publicar em
Revista Portuguesa de Cardiologia
A revista pertence ao Committee on Publication Ethics (COPE) www.publicationethics.org e adere aos seus princípios e procedimentos.